Molecular characterisation of bacteria in sputum samples from severe asthma

S. Wiriyachaiporn, B. Green, V. Kehagia, M. Carroll, P. Howarth, K. Bruce (London, Southampton, United Kingdom)

Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Session: Mechanisms of respiratory infections: interaction between the pathogen and the host
Session type: Thematic Poster Session
Number: 2291
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Wiriyachaiporn, B. Green, V. Kehagia, M. Carroll, P. Howarth, K. Bruce (London, Southampton, United Kingdom). Molecular characterisation of bacteria in sputum samples from severe asthma. Eur Respir J 2008; 32: Suppl. 52, 2291

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Spectrum of sputum microflora during infectious exacerbation of bronchial asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Immunometabolic markers and the sputum microbiome in bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021



Applications of induced sputum sampling in asthma and COPD
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018



Sputum proteomics of CF, BE and COPD with or without NTM infections
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021


Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis?
Source: Eur Respir J 2007; 30: Suppl. 51, 31s
Year: 2007

Spontaneous sputum production as a marker of bacterial colonisation in stable COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005


Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Source: Eur Respir J 2015; 46: 688-696
Year: 2015



Microbiological yield of BAL as part of bronchial sepsis screen
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016



Induced sputum concentrations of mucin in patients with asthma and chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 61s
Year: 2007

Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004

Comparison of blood and sputum analysis in evaluation of eosinophilic COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Induced sputum: time from expectoration to processing
Source: Eur Respir J 2002; 19: 706-708
Year: 2002